Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin effects on sleep EEG slow-wave activity and glucose tolerance in diabetic polyneuropathy
2011-004371-36Phase 4Active
- Sponsor
- Instituto de Investigaciones del Sueño
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pregabalin in diabetic polyneuropathy (DPN) (2 arms), sponsored by Instituto de Investigaciones del Sueño. Primary endpoint: Change in slow-wave activity in the delta band during sleep EEG. Started Nov 2011; status: active.
02
Drugs
pregabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2011-004371-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004371-36.